AAAAAA
Results:
1-20
|
Results: 20
Authors:
CAPPELLI M
VERMA S
KOMELUK Y
TOMIAK E
DEGRASSE C
CORSINI L
HUMPHREYS L
Citation: M. Cappelli et al., ASSESSING THE PSYCHOLOGICAL FUNCTIONING AND HEALTH-CARE CHOICES OF ADOLESCENT DAUGHTERS OF BREAST-CANCER PATIENTS, European journal of cancer, 34, 1998, pp. 570-570
Authors:
PARIDAENS R
ROY JA
NOOIJ M
KLIJN J
HOUSTON SJ
BEEX LVAM
VINHOLES J
TOMIAK E
VANVRECKEM A
LANGENAEKEN C
VANGLABBEKE M
PICCART MJ
Citation: R. Paridaens et al., VOROZOLE (RIVIZOR(TM)) - AN ACTIVE AND WELL TOLERATED NEW AROMATASE INHIBITOR FOR THE TREATMENT OF ADVANCED BREAST-CANCER PATIENTS WITH PRIOR TAMOXIFEN EXPOSURE, Anti-cancer drugs, 9(1), 1998, pp. 29-35
Authors:
THERASSE P
MAURIAC L
WELNICKA M
BRUNING P
CUFER T
TOMIAK E
CURRAN D
RAMIREZ A
KOOPMANSCHAP M
PICCART M
Citation: P. Therasse et al., AN EORTC-NCIC-SAKK NEOADJUVANT RANDOMIZED PHASE-III STUDY COMPARING CEF (5FU, EPIRUBICIN, CYCLOPHOSPHAMIDE) VS DOSE INTENSIFIED EC-CSF (FILGRASTIM) IN LOCALLY ADVANCED BREAST-CANCER (LABC) - UPDATED RESULTS INCLUDING QUALITY-OF-LIFE(G), Annals of oncology, 9, 1998, pp. 63-63
Authors:
GELMON K
TOMIAK E
TOLCHER T
BLACKSTEIN M
ZEE B
BATIST G
IGLESIAS J
FISHER B
EISENHAUER E
Citation: K. Gelmon et al., RANDOMIZED TRIAL OF HIGH-DOSE PACLITAXEL (TAXOL, T) PLUS MINUS AMIFOSTINE (A) IN METASTATIC BREAST-CANCER (MBC) - A STUDY OF THE NCIC CLINICAL-TRIALS GROUP (CTG)/, Annals of oncology, 9, 1998, pp. 371-371
Authors:
GINSBURG AD
LEVINE MN
BOWMAN DM
OLIVOTTO IA
FIELDS LA
LITTLE CD
CANTIN J
MCGREGOR M
GOLDHIRSCH A
BRAMWELL V
GELMON K
BRYCE C
ALLAN S
NORRIS B
LATREILLE J
PATERSON ADH
TOMIAK E
TREMBLAY G
BAIRD R
BECKER P
BUTTS C
DANCEY JT
GOEL R
KVERN B
MILNE C
NAROD S
NOLAN E
THURLOW WH
WONG R
Citation: Ad. Ginsburg et al., ADJUVANT SYSTEMIC THERAPY FOR WOMEN WITH NODE-NEGATIVE BREAST-CANCER, CMAJ. Canadian Medical Association journal, 158, 1998, pp. 43-51
Authors:
ROUINI MR
LOTFOLAHI A
STEWART DJ
MOLEPO JM
SHIRAZI FH
VERGNIOL JC
TOMIAK E
DELORME F
VERNILLET L
GIGUERE M
GOEL R
Citation: Mr. Rouini et al., A RAPID REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHODFOR THE DETERMINATION OF DOCETAXEL (TAXOTERE(R)) IN HUMAN PLASMA USING A COLUMN-SWITCHING TECHNIQUE, Journal of pharmaceutical and biomedical analysis, 17(8), 1998, pp. 1243-1247
Authors:
STEWART DJ
GOEL R
CRIPPS MC
YAU J
HUAN S
TOMIAK E
DAVIES RA
DULUDE H
GALLANT G
Citation: Dj. Stewart et al., CONCURRENT USE OF MULTIPLE CHEMOTHERAPY RESISTANCE MODULATORS WITH ETOPOSIDE IN PATIENTS WITH RESISTANT MALIGNANCIES, International journal of oncology, 11(4), 1997, pp. 709-716
Authors:
EVANS WK
LEPETIT C
WILL BP
BERTHELOT JM
TOMIAK E
VERMA S
Citation: Wk. Evans et al., OPPORTUNITIES TO REDUCE THE COST OF CARE FOR BREAST-CANCER (BC) IN CANADA, European journal of cancer, 33, 1997, pp. 20-20
Authors:
AWADA A
VANVRECKEM A
PARIDAENS R
BRUNING PF
KLIJN J
TOMIAK E
VINHOLES J
ROY JA
KUSENDA Z
BOES GH
VANGLABBEKE M
PICCART MJ
Citation: A. Awada et al., EORTC-IDBBC (INVESTIGATIONAL DRUG BRANCH FOR BREAST-CANCER) - 5 YEARSOF EUROPEAN COLLABORATION IN NEW DRUG DEVELOPMENT FOR BREAST-CANCER, European journal of cancer, 33(8), 1997, pp. 1173-1176
Authors:
STEWART DJ
CRIPPS MC
GOEL R
DAHROUGE S
YAU J
TOMIAK E
HUAN S
SOLTYS K
PROSSER A
DAVIES RA
Citation: Dj. Stewart et al., PILOT-STUDY OF MULTIPLE CHEMOTHERAPY RESISTANCE MODULATORS PLUS EPIRUBICIN IN THE TREATMENT OF RESISTANT MALIGNANCIES, Cancer chemotherapy and pharmacology, 41(1), 1997, pp. 1-8
Authors:
EVANS WK
EARLE CC
STEWART DJ
DAHROUGE S
TOMIAK E
GOSS G
LOGAN D
GOEL R
GERTLER SZ
DULUDE H
Citation: Wk. Evans et al., PHASE-II STUDY OF A ONE-HOUR PACLITAXEL INFUSION IN COMBINATION WITH CARBOPLATIN FOR ADVANCED NONSMALL CELL LUNG-CANCER, Lung cancer, 18(1), 1997, pp. 83-94
Authors:
TOMIAK E
PICCART M
MIGNOLET F
SAHMOUD T
PARIDAENS R
NOOY M
BEEX L
FENTIMAN IS
MULLER A
VANDERSCHUEREN E
RUBENS RD
Citation: E. Tomiak et al., CHARACTERIZATION OF COMPLETE RESPONDERS TO COMBINATION CHEMOTHERAPY FOR ADVANCED BREAST-CANCER - A RETROSPECTIVE EORTC BREAST GROUP-STUDY, European journal of cancer, 32A(11), 1996, pp. 1876-1887
Authors:
SHEPHERD FA
LATREILLE J
CRUMP M
STEWART D
TOMIAK E
EISENHAUER E
FISHER B
Citation: Fa. Shepherd et al., PHASE-I STUDY OF PACLITAXEL (TAXOL(TM)) AND IFOSFAMIDE IN PREVIOUSLY UNTREATED PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER - A STUDY OF THE NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALS GROUP, Annals of oncology, 7(3), 1996, pp. 311-313
Authors:
HUAN SD
YAU JC
TOMIAK E
GOEL R
CRIPPS C
GERTLER SZ
PROSSER IA
STEWART DJ
Citation: Sd. Huan et al., HYDROXYUREA DID NOT ENHANCE THE CLINICAL-RESPONSE TO VINBLASTINE IN PATIENTS WITH ANTHRACYCLINE-RESISTANT METASTATIC BREAST-CANCER, Tumori, 82(6), 1996, pp. 576-578
Authors:
THERASSE R
TSITSA C
SAHMOUD T
TOMIAK E
GOLDHIRSCH A
PICCART M
Citation: R. Therasse et al., NEOADJUVANT CHEMOTHERAPY IN LOCALLY ADVANCED BEAST CANCER (LABC) - FEC (5FU, EPIRUBICIN, CYCLOPHOSPHAMLDE) VS HIGH-DOSE INTENSITY EC-CSF (FILGRASTIM) - AN EORTC-NCIC-SAKK STUDY - PRELIMINARY-RESULTS OF DOSE INTENSITY (DI)(G), European journal of cancer, 31A, 1995, pp. 372-372
Authors:
LOCHRIN C
GOSS G
CROSS P
STEWART D
TOMIAK E
AGBOOLA O
AREF I
REID K
GIRARD A
LOGAN D
CREPEAU A
DAHROUGE S
EVANS WK
Citation: C. Lochrin et al., CONCURRENT DAILY CHEMOTHERAPY WITH HYPERFRACTIONATED THORACIC IRRADIATION IN STAGE IIIA-AND-B NSCLC, European journal of cancer, 31A, 1995, pp. 1100-1100
Authors:
PICCART MJ
BRUNING P
WILDIERS J
AWADA A
SCHORNAGEL JH
THOMAS J
TOMIAK E
BARTHOLOMEUS S
WITTEVEEN PO
PARIDAENS R
Citation: Mj. Piccart et al., AN EORTC PILOT-STUDY OF FILGRASTIM (RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR) AS SUPPORT TO A HIGH DOSE-INTENSIVE EPIADRIAMYCIN-CYCLOPHOSPHAMIDE REGIMEN IN CHEMOTHERAPY-NAIVE PATIENTS WITH LOCALLY ADVANCED OR METASTATIC BREAST-CANCER, Annals of oncology, 6(7), 1995, pp. 673-677
Authors:
EVANS WK
RADWI A
TOMIAK E
LOGAN DM
MARTINS H
STEWART DJ
GOSS G
MAROUN JA
DAHROUGE S
Citation: Wk. Evans et al., ORAL ETOPOSIDE AND CARBOPLATIN - EFFECTIVE THERAPY FOR ELDERLY PATIENTS WITH SMALL-CELL LUNG-CANCER, American journal of clinical oncology, 18(2), 1995, pp. 149-155
Authors:
TOMIAK E
PICCART MJ
KERGER J
LIPS S
AWADA A
DEVALERIOLA D
RAVOET C
LOSSIGNOL D
SCULIER JP
AUZANNET V
LEBAIL N
BAYSSAS M
KLASTERSKY J
Citation: E. Tomiak et al., PHASE-I STUDY OF DOCETAXEL ADMINISTERED AS A 1-HOUR INTRAVENOUS-INFUSION ON A WEEKLY BASIS, Journal of clinical oncology, 12(7), 1994, pp. 1458-1467
Authors:
PICCART MJ
DEVALERIOLA D
TOMIAK E
Citation: Mj. Piccart et al., ANTHRACYCLINES ACTIVE VIA THE ORAL ROUTE - LUXURY OR NECESSITY, Annals of oncology, 3(3), 1992, pp. 181-182
Risultati:
1-20
|